Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue 6
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis - January 01, 2024
PDF
PDF +
Supplementary
Material
Immunotherapy biomarkers
Original research
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
Online download statistics by month:
Online download statistics by month: June 2023 to October 2024
Abstract
Full
Pdf
Jun 2023
628
642
157
Jul 2023
324
326
55
Aug 2023
211
212
24
Sep 2023
106
106
20
Oct 2023
125
129
33
Nov 2023
150
150
35
Dec 2023
106
107
66
Jan 2024
140
141
97
Feb 2024
118
119
73
Mar 2024
123
123
224
Apr 2024
90
90
80
May 2024
111
115
87
Jun 2024
90
91
55
Jul 2024
103
112
78
Aug 2024
69
77
52
Sep 2024
58
58
835
Oct 2024
109
109
74
Total
2661
2707
2045
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?